Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy

Introduction: The causal relation between STN-DBS and speech problems and the associated clinical features are in the incipient stages of being investigated. Methods: All the Parkinson's disease (PD) subjects with and without STN-DBS who applied to our movement disorders outpatient clinics betw...

Full description

Bibliographic Details
Main Authors: Halil Onder, Zeynep Tuba Bahtiyarca, Selcuk Comoglu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=491;epage=495;aulast=Onder
_version_ 1797649525829009408
author Halil Onder
Zeynep Tuba Bahtiyarca
Selcuk Comoglu
author_facet Halil Onder
Zeynep Tuba Bahtiyarca
Selcuk Comoglu
author_sort Halil Onder
collection DOAJ
description Introduction: The causal relation between STN-DBS and speech problems and the associated clinical features are in the incipient stages of being investigated. Methods: All the Parkinson's disease (PD) subjects with and without STN-DBS who applied to our movement disorders outpatient clinics between January 2022 and June 2022 and agreed to participate in the study were enrolled. The demographic data and clinical features were noted. Besides, the MDS-UPDRS was administered during the medication off-state in all subjects. All the participants completed the voice handicap index (VHI). Besides, the Freezing of Gait Questionnaire (FOGQ) and the quality of life (QoL) scales including the Parkinson's Disease Questionnaire (PDQ-39) and the Schwab and England Activities of Daily Living (ADL) scale were also administered to all the individuals. Results: We have included 66 patients with PD (F/M = 23/43). Thirty-five patients were those with DBS therapy whereas 31 patients were without. The results of the comparative analyses between the patients with and without DBS therapy revealed that the DBS group had a higher disease duration (P = 0.006) and FOGQ scores (P = 0.008). The VHI scores did not differ between groups (P = 0.577), and the correlation analyses did not reveal an association between the VHI scores and the duration of DBS therapy. However, the VHI scores correlated with the disease duration as well as the FOG scores. Conclusion: We did not find convincing evidence supporting the increased risk of speech disturbance with STN-DBS therapy. We suggest that the frequent existence of speech disturbance in this patient subgroup with STN-DBS is associated with the classical nature of PD.
first_indexed 2024-03-11T15:47:25Z
format Article
id doaj.art-c212a5697e0f4b81911577a71c62a8b0
institution Directory Open Access Journal
issn 0972-2327
1998-3549
language English
last_indexed 2024-03-11T15:47:25Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Indian Academy of Neurology
spelling doaj.art-c212a5697e0f4b81911577a71c62a8b02023-10-26T05:44:42ZengWolters Kluwer Medknow PublicationsAnnals of Indian Academy of Neurology0972-23271998-35492023-01-0126449149510.4103/aian.aian_1_23Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapyHalil OnderZeynep Tuba BahtiyarcaSelcuk ComogluIntroduction: The causal relation between STN-DBS and speech problems and the associated clinical features are in the incipient stages of being investigated. Methods: All the Parkinson's disease (PD) subjects with and without STN-DBS who applied to our movement disorders outpatient clinics between January 2022 and June 2022 and agreed to participate in the study were enrolled. The demographic data and clinical features were noted. Besides, the MDS-UPDRS was administered during the medication off-state in all subjects. All the participants completed the voice handicap index (VHI). Besides, the Freezing of Gait Questionnaire (FOGQ) and the quality of life (QoL) scales including the Parkinson's Disease Questionnaire (PDQ-39) and the Schwab and England Activities of Daily Living (ADL) scale were also administered to all the individuals. Results: We have included 66 patients with PD (F/M = 23/43). Thirty-five patients were those with DBS therapy whereas 31 patients were without. The results of the comparative analyses between the patients with and without DBS therapy revealed that the DBS group had a higher disease duration (P = 0.006) and FOGQ scores (P = 0.008). The VHI scores did not differ between groups (P = 0.577), and the correlation analyses did not reveal an association between the VHI scores and the duration of DBS therapy. However, the VHI scores correlated with the disease duration as well as the FOG scores. Conclusion: We did not find convincing evidence supporting the increased risk of speech disturbance with STN-DBS therapy. We suggest that the frequent existence of speech disturbance in this patient subgroup with STN-DBS is associated with the classical nature of PD.http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=491;epage=495;aulast=Onderparkinson's diseasespeechstn-dbsvoice handicap index
spellingShingle Halil Onder
Zeynep Tuba Bahtiyarca
Selcuk Comoglu
Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
Annals of Indian Academy of Neurology
parkinson's disease
speech
stn-dbs
voice handicap index
title Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
title_full Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
title_fullStr Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
title_full_unstemmed Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
title_short Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
title_sort subjective assessments of voice in parkinson s disease subjects with and without stn dbs therapy
topic parkinson's disease
speech
stn-dbs
voice handicap index
url http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=491;epage=495;aulast=Onder
work_keys_str_mv AT halilonder subjectiveassessmentsofvoiceinparkinsonsdiseasesubjectswithandwithoutstndbstherapy
AT zeyneptubabahtiyarca subjectiveassessmentsofvoiceinparkinsonsdiseasesubjectswithandwithoutstndbstherapy
AT selcukcomoglu subjectiveassessmentsofvoiceinparkinsonsdiseasesubjectswithandwithoutstndbstherapy